Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
69,641
52-wk High
$2.64
52-wk Low
$0.31

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $10.73
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Tenax Therapeutics says company's board is continuing its review of strategic alternatives

* Tenax Therapeutics provides regulatory update on Levosimendan

Jul 28 2017

BRIEF-Asterias Biotherapeutics completes enrollment and dosing of a cohort of an early-stage study

* Asterias Biotherapeutics completes enrollment and dosing of scistar study's ais-a 20 million cell cohort

Jul 17 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.20 -0.35
Merck & Co., Inc. (MRK.N) $57.07 +0.73
Roche Holding Ltd. (ROG.S) CHF240.40 -1.30
Roche Holding Ltd. (RO.S) CHF243.10 -0.90
Abbott Laboratories (ABT.N) $55.70 +0.76
Bayer AG (BAYGn.DE) €106.20 -0.45
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.62 -0.41
Eli Lilly and Co (LLY.N) $86.71 +0.04
Bristol-Myers Squibb Co (BMY.N) $63.28 +0.26

Earnings vs. Estimates